塞栓防止装置市場：装置タイプ、用途、エンドユーザー別-2025～2030年の世界予測

塞栓防止装置市場は、2023年に17億2,000万米ドルと評価され、2024年には18億6,000万米ドルに達すると予測され、CAGR 8.11%で成長し、2030年には29億8,000万米ドルになると予測されています。

塞栓防止装置（EPD）は、経皮的冠動脈インターベンション（PCI）や経カテーテル大動脈弁置換術（TAVR）などの手技中に外れた破片を捕捉して除去するように設計された、インターベンショナル心血管系手技において重要な役割を果たします。その必要性は、脳卒中や心筋梗塞の原因となる重大な合併症である塞栓症を予防する必要性から生じています。これらの装置は、主に心臓血管系を中心とした様々な手技に応用されており、最終用途市場は病院、心臓センター、外来手術センターにまで及んでいます。EPD市場の成長は、心血管疾患の有病率の増加と低侵襲手術手技への嗜好の高まりに影響されています。さらに、患者の安全性や手術効果の向上など、機器設計の技術的進歩が市場をさらに牽引しています。注目すべきビジネス機会は、医療インフラが力強く開拓され、熟練した専門家の増加や心血管の健康に関する患者の意識が高まっている新興国市場にあります。しかし、同市場は、機器の高コスト、規制上のハードル、これらの先端技術を効率的に運用するための熟練者の必要性などの制約に直面しています。課題には、市場浸透の妨げとなる激しい競争や償還の問題などがあります。開発にあたっては、人工知能と機械学習を統合して機器の機能性と患者の予後を向上させるとともに、再利用可能で費用対効果の高い機器を開発してアクセシビリティを広げることに注力すべきです。研究機関との提携や協力関係を模索することで、革新的なソリューションを育成することもできます。EPD市場の性質はダイナミックであり、絶え間ない技術の進歩と臨床ニーズの進化に後押しされています。こうした変化に適応し、規制やコストの制約に対処しながら患者中心のソリューションに注力できる企業は、市場での地位を強化し、事業の大幅な成長を促進することができます。

市場力学：急速に進化する塞栓防止装置市場の主要市場洞察を公開

塞栓防止装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患と心臓疾患の増加
  • 心臓の健康に対する意識を高め、心臓疾患の診断を改善するための政府のイニシアティブの高まり
  • 手術センターの拡大、塞栓防止装置の研究へのクリニックの関与
• 市場抑制要因
  • 塞栓防止装置またはシステムの製品回収の発生
• 市場機会
  • 塞栓防止装置の機能性、安全性、効率性を向上させるための継続的な技術革新
  • 塞栓防止装置の認可に対する規制当局の承認とサポート
• 市場課題
  • 塞栓防止装置の性能問題と技術的複雑性

ポーターのファイブフォース：塞栓防止装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、塞栓防止装置市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活用し、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：塞栓防止装置市場における外部からの影響の把握

外部マクロ環境要因は、塞栓防止装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：塞栓防止装置市場における競合情勢の把握

塞栓防止装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：塞栓防止装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、塞栓防止装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：塞栓防止装置市場における成功への道筋を描く

塞栓防止装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患や心臓疾患の発生率の増加
    • 心臓の健康に対する意識を高め、心臓病の診断を改善するための政府の取り組みが拡大
    • 外科センターの拡大と塞栓防止装置の調査調査へのクリニックの関与
  • 抑制要因
    • 塞栓防止装置またはシステムの製品リコールの発生
  • 機会
    • 塞栓防止装置の機能性、安全性、効率性を向上させるための継続的なイノベーション
    • 塞栓防止装置の認可に関する規制承認とサポート
  • 課題
    • 塞栓防止装置のパフォーマンスの問題と技術的な複雑さ
• 市場セグメンテーション分析
  • 装置タイプ：柔軟性、有効性、低侵襲性により遠位フィルターの採用が拡大
  • 用途：大量の心血管介入と手術を管理するための塞栓防止装置の必要性の拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 塞栓防止装置市場：装置タイプ別

• イントロダクション
• 遠位フィルター
• 遠位閉塞装置
• 近位閉塞装置

第7章 塞栓防止装置市場：用途別

• イントロダクション
• 心臓血管手術
• 神経血管手術

第8章 塞栓防止装置市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの塞栓防止装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の塞栓防止装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの塞栓防止装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Protembis GmbH、PROTEMBO脳保護検査の加速に向けシリーズB資金調達で3,247万米ドルを確保
  • AorticLab、革新的なFLOWer塞栓保護装置でCEマーク承認を取得
  • EnCompass Technologies、F2脳保護システム研究のFDA承認でマイルストーンを達成
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AngioDynamics, Inc.
• Balton Sp. z o. o.
• Boston Scientific Corporation
• Contego Medical, Inc.
• Cook Group Incorporated
• Cordis
• Edwards Lifesciences Corporation
• Emboline, Inc.
• Filterlex Medical Ltd.
• Inari Medical, Inc.
• InspireMD Inc.
• Invamed
• Keystone Heart US, Inc. by Venus Medtech（Hangzhou）Inc.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• NIPRO CORPORATION
• Penumbra, Inc.
• Protembis GmbH
• Silk Road Medical, Inc.
• Stryker Corporation
• Terumo Medical Corporation
• Transverse Medical Inc.
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. EMBOLIC PROTECTION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. EMBOLIC PROTECTION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. EMBOLIC PROTECTION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL FILTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DISTAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY CARDIOVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY NEUROVASCULAR PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM EMBOLIC PROTECTION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. EMBOLIC PROTECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. EMBOLIC PROTECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Embolic Protection Devices Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 2.98 billion by 2030.

Embolic protection devices (EPDs) are critical in interventional cardiovascular procedures, designed to capture and remove debris that dislodges during procedures such as percutaneous coronary interventions (PCIs) and transcatheter aortic valve replacements (TAVRs). Their necessity stems from the need to prevent embolism, a major complication that can lead to strokes or myocardial infarctions. These devices find applications in various procedures, primarily focusing on the cardiovascular system, with end-use markets extending to hospitals, cardiac centers, and ambulatory surgical units. The growth of the EPD market is influenced by the increasing prevalence of cardiovascular diseases and a heightened preference for minimally invasive surgical techniques. Additionally, technological advancements in device design, such as improving patient safety and procedural efficacy, further drive the market. Notable opportunities lie in emerging markets where healthcare infrastructure is experiencing robust development, alongside an increasing number of skilled professionals and patient awareness regarding cardiovascular health. However, the market faces limitations such as high costs of devices, regulatory hurdles, and the need for skilled personnel to operate these advanced technologies efficiently. Challenges include intense competition and reimbursement issues which can impede market penetration. Innovation should focus on integrating artificial intelligence and machine learning to enhance device functionality and patient outcomes, as well as developing reusable and cost-effective devices to broaden accessibility. Exploring partnerships or collaborations with research institutions can also foster innovative solutions. The EPD market's nature is dynamic, driven by constant technological advancements and evolving clinical needs. Companies that can adapt to these changes and focus on patient-centered solutions, while addressing regulatory and cost constraints, stand to strengthen their market position and drive significant business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolic Protection Devices Market

The Embolic Protection Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of cardiovascular diseases and heart issues
  • Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
  • Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
• Market Restraints
  • Incidences of product recall of embolic protection devices or systems
• Market Opportunities
  • Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
  • Regulatory approvals and support for authorization of embolic protection devices
• Market Challenges
  • Performance issues and technical complexity of embolic protection devices

Porter's Five Forces: A Strategic Tool for Navigating the Embolic Protection Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolic Protection Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolic Protection Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolic Protection Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolic Protection Devices Market

A detailed market share analysis in the Embolic Protection Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolic Protection Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolic Protection Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolic Protection Devices Market

A strategic analysis of the Embolic Protection Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolic Protection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Balton Sp. z o. o., Boston Scientific Corporation, Contego Medical, Inc., Cook Group Incorporated, Cordis, Edwards Lifesciences Corporation, Emboline, Inc., Filterlex Medical Ltd., Inari Medical, Inc., InspireMD Inc., Invamed, Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NIPRO CORPORATION, Penumbra, Inc., Protembis GmbH, Silk Road Medical, Inc., Stryker Corporation, Terumo Medical Corporation, Transverse Medical Inc., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Embolic Protection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device Type, market is studied across Distal Filters, Distal Occlusion Devices, and Proximal Occlusion Devices.
• Based on Application, market is studied across Cardiovascular Procedures and Neurovascular Procedures.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of cardiovascular diseases and heart issues
    • 5.1.1.2. Growing government initiatives to raise awareness for heart health and improve diagnosis of heart conditions
    • 5.1.1.3. Expansion of surgical centers and involvement of clinics in research studies for embolic protection devices
  • 5.1.2. Restraints
    • 5.1.2.1. Incidences of product recall of embolic protection devices or systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations to improve functionality, safety, and efficiency of embolic protection devices
    • 5.1.3.2. Regulatory approvals and support for authorization of embolic protection devices
  • 5.1.4. Challenges
    • 5.1.4.1. Performance issues and technical complexity of embolic protection devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Emerging adoption of distal filters owing to their flexibility, effectiveness, and minimally invasive nature
  • 5.2.2. Application: Expanding need for embolic protection devices to manage the large volume of cardiovascular interventions and surgeries
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Embolic Protection Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Distal Filters
• 6.3. Distal Occlusion Devices
• 6.4. Proximal Occlusion Devices

7. Embolic Protection Devices Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Procedures
• 7.3. Neurovascular Procedures

8. Embolic Protection Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Embolic Protection Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Embolic Protection Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Embolic Protection Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Protembis GmbH Secures USD 32.47 Million in Series B Funding to Accelerate the PROTEMBO Cerebral Protection Trial
  • 12.3.2. AorticLab Achieves CE Mark Approval for Innovative FLOWer Embolic Protection Device
  • 12.3.3. EnCompass Technologies Achieves Milestone with FDA Approval for F2 Cerebral Protection System Study
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AngioDynamics, Inc.
• 3. Balton Sp. z o. o.
• 4. Boston Scientific Corporation
• 5. Contego Medical, Inc.
• 6. Cook Group Incorporated
• 7. Cordis
• 8. Edwards Lifesciences Corporation
• 9. Emboline, Inc.
• 10. Filterlex Medical Ltd.
• 11. Inari Medical, Inc.
• 12. InspireMD Inc.
• 13. Invamed
• 14. Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc.
• 15. Medtronic PLC
• 16. Meril Life Sciences Pvt. Ltd.
• 17. MicroPort Scientific Corporation
• 18. NIPRO CORPORATION
• 19. Penumbra, Inc.
• 20. Protembis GmbH
• 21. Silk Road Medical, Inc.
• 22. Stryker Corporation
• 23. Terumo Medical Corporation
• 24. Transverse Medical Inc.
• 25. W. L. Gore & Associates, Inc.